The mGlu7 is considered a therapeutic target for several psychiatric and neurological disorders, and GRM7 polymorphisms have been linked to schizophrenia, depression, autism, and ADHD [28,29,30,31,32]. The gene discussed is GRM7; the disease is attention deficit-hyperactivity disorder.